Powered by machine learning and deep learning technologies, PathAI‘s solution not only identifies biomarkers of disease but is also able to predict responses to treatments, while continuously advancing and improving the work of pathologists and pharmaceutical researchers. PathAI‘s promising solution has so far secured 3 multi-million funding rounds and is backed by industry-leading partners. Launched […]
